UCB.BR : Summary for UCB - Yahoo Finance

U.S. Markets closed


Brussels - Brussels Delayed Price. Currency in EUR
Add to watchlist
71.58-0.87 (-1.20%)
At close: 5:35PM CEST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close72.45
Bid64.00 x 203800
Ask66.00 x 10000
Day's Range71.53 - 72.31
52 Week Range54.84 - 74.72
Avg. Volume320,166
Market Cap13.51B
PE Ratio (TTM)25.95
Earnings DateN/A
Dividend & Yield1.27 (1.64%)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire2 days ago

    UCB showcases latest epilepsy research at 2017 Annual Meeting of the American Academy of Neurology

    Data being presented include posters further describing the efficacy and tolerability profile of VIMPAT® (lacosamide) CV and BRIVIACT® (brivaracetam) CV. Posters will be presented describing the efficacy and tolerability of lacosamide monotherapy in elderly newly diagnosed epilepsy patients and in newly diagnosed epilepsy patients with psychiatric comorbidities. Pooled results from long-term follow-up studies of adjunctive brivaracetam in patients with secondarily generalized tonic-clonic seizures and a poster comparing the healthcare utilization and direct medical costs in newly diagnosed epilepsy patients compared to a non-epilepsy population will also be presented.

  • PR Newswire12 days ago

    Labor Commissioner Mark Butler Joins Atlanta Businesses at the EFWorks Launch Forum

    ATLANTA, April 11, 2017 /PRNewswire/ -- The Epilepsy Foundation of Georgia (EFGA), with sponsorship from UCB, Inc., a biopharmaceutical company, had the pleasure of hosting Georgia Labor Commissioner Mark Butler and Atlanta-area business at the EFWorks Employer Forum. Attendees included companies large and small.

  • PR Newswire12 days ago

    1CellBiO Inc announces Collaboration Agreement with UCB

    CAMBRIDGE, Mass., April 11, 2017 /PRNewswire/ -- 1CellBiO Inc announced today a research collaboration with UCB to validate and deploy the inDrop ™ high throughput single cell RNA sequencing platform in ...